Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol testing by general practitioners in Grampian: patterns and outcomes

B H Smith1, V Vranjkovic, S R McEwan

  • 1Department of General Practice, University of Aberdeen, Foresterhill Health Centre.

Scottish Medical Journal
|June 1, 1996
PubMed
Summary

This study looked at how cholesterol testing is handled in general practices in the Grampian region. Researchers analyzed data from nearly 5,000 patients and found a wide range in how often different practices ordered cholesterol tests. They also noticed that the rate of prescribing lipid-lowering drugs varied similarly across practices. The study found that cholesterol testing was generally in line with cardiovascular risk guidelines and was often followed by additional assessments. A notable finding was a 'rule of halves' pattern in follow-up testing. The results suggest that testing and prescription behaviors are closely linked, and that there is significant variation in how general practices manage cholesterol testing and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceived barriers to and facilitators of physical activity, using the COM-B model for behavioural change, in people with chronic pain: a qualitative evaluation of patient and stakeholder perspectives.

BMC public health·2025
Same author

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.

Nature medicine·2021
Same author

Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality.

BMC infectious diseases·2021
Same author

Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis.

British journal of anaesthesia·2019
Same author

Community characteristics modify the relationship between obesity prevention efforts and dietary intake in children: the Healthy Communities Study.

Pediatric obesity·2018
Same author

Associations of community programs and policies with children's dietary intakes: the Healthy Communities Study.

Pediatric obesity·2018

Area of Science:

  • Primary care diagnostics in cardiovascular medicine
  • Public health epidemiology of lipid screening
  • Clinical decision-making in general practice

Background:

Prior research has shown that cardiovascular risk assessment often includes cholesterol testing. It was already known that general practitioners use various biochemical tests to evaluate patient risk profiles. No prior work had resolved how cholesterol testing is distributed across primary care settings. That uncertainty drove this study’s focus on testing patterns in a specific region. This gap motivated an examination of testing rates and their correlation with prescription behaviors. Known knowledge includes the importance of lipid profiles in cardiovascular risk stratification. This paper's contribution is a detailed analysis of how testing is initiated and followed up in real-world general practice. The study provides insights into variability among practices and its implications for patient care.

Purpose Of The Study:

The aim of this study was to examine how cholesterol testing is initiated and followed up in general practice settings. The specific problem addressed is the variability in testing rates and outcomes across different practices. This study sought to measure testing distribution and its relationship with prescription behaviors. The motivation for this research stems from the need to understand how cardiovascular risk is managed in primary care. The study also aimed to assess the correlation between testing frequency and lipid-lowering agent prescriptions. It was important to determine whether testing practices align with established cardiovascular risk guidelines. The study focused on a single region to allow for a detailed and localized analysis. This approach enabled the researchers to explore patterns and outcomes within a defined population.

Keywords:
Cholesterol testing patternsGeneral practice cardiovascular riskLipid-lowering drug prescriptionsPrimary care diagnostic variability

Frequently Asked Questions

The study found a 90-fold range in cholesterol testing rates among general practices and a similar range in lipid-lowering agent prescriptions.

The subset analysis included age, sex, cholesterol test results, follow-up actions, and associated biochemical tests.

The authors suggest that follow-up testing patterns indicate a need for further investigation into how testing is managed in primary care.

The significant correlation suggests a potential link between testing frequency and clinical decision-making in prescribing lipid-lowering agents.

Related Experiment Videos

Main Methods:

The study analyzed data from 4979 patients across general practices in Grampian. A subset of 215 patients was selected for detailed analysis. The data included age, sex, cholesterol test results, and follow-up actions. The researchers also examined the types of associated biochemical tests performed. Testing initiation and frequency were measured across different practices. Prescription rates of lipid-lowering agents were compared with testing rates. The study used a combination of quantitative analysis and descriptive statistics. The findings were synthesized to evaluate patterns and correlations in testing and treatment.

Main Results:

The study found a 90-fold variation in cholesterol testing rates among practices. A similar range was observed in lipid-lowering agent prescriptions. Testing was generally aligned with cardiovascular risk guidelines. The results showed a significant correlation between testing and prescription behaviors. Follow-up testing suggested a 'rule of halves' pattern for cholesterol testing. The data revealed that testing was often accompanied by further cardiovascular assessments. Age and sex distributions were consistent with general population trends. The findings highlight variability in clinical decision-making across primary care settings.

Conclusions:

The authors stated that cholesterol testing in general practice is broadly consistent with cardiovascular risk guidelines. They proposed that testing is often followed by further assessments and prescriptions. The wide variation in testing rates suggests differences in clinical practice. The correlation between testing and prescriptions indicates a potential link in decision-making. The 'rule of halves' pattern implies a need for further investigation into follow-up behaviors. The study's findings suggest that variability in practice may affect patient outcomes. The authors did not assign essentiality to any specific testing approach. Their conclusions emphasize the importance of understanding regional variations in care delivery.

Failed At:

2026-07-14T07:44:58.983413+00:00

A random sample of 215 patients was selected from the 4979 total patients included in the study.

The authors propose that wide variations in testing and prescription rates may reflect differences in clinical practice approaches.